Tradestie Institutional Equity Comparison Engine
RAPP vs PVLA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PVLA Overall Edge
PVLA Captures Institutional Edge (3โ0 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RAPP trades at N/M Forward P/E with -838.1% operating margin (+0.0% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RAPP sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
RAPP N/M vs PVLA N/M Fwd P/E
Growth & Margin Winner
PVLA
Op Margin -838.1% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
PVLA
1Y +2.5% vs +80.2% ยท 52W Pos 10% vs 68%
Options & Structure Winner
PVLA
BREAKDOWN (6th %ile IV) vs CONSOLIDATION (2nd %ile IV)
RAPP
NASDAQ
Rapport Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$25.29
-3.29% 1D
Market Cap
$1.5B
1M Return
-8.27%
1Y Return
+2.51%
Forward P/E
N/M
Unified AI Score
51.5 / 100
HOLD
Tech 64.0
Fund 60.0
Flow 68.0
Mom 58.9
PVLA
NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap
$2.2B
1M Return
+20.56%
1Y Return
+80.16%
Forward P/E
N/M
Unified AI Score
48.2 / 100
HOLD
Tech 35.0
Fund 53.0
Flow 67.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RAPP +2.51%
PVLA +80.16%
Spread: +77.65 pp (PVLA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RAPP TTM Op. Margin: -838.1%
PVLA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAPP vs PVLA. Trailing 12-month operating profitability (RAPP -838.1% vs PVLA 0.0%) and valuation multiples (RAPP N/M vs PVLA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RAPP | PVLA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $2.2B | Larger Scale | PVLA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | -838.1% | 0.0% | Higher Margin | PVLA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -33.3% | -63.4% | Higher ROE | RAPP |
| 52-Week Range Position Momentum | 10% ($22โ$53) | 68% ($72โ$180) | Stronger Trend | PVLA |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 109% Vol | 1.66ฮฒ ยท 75% Vol | Lower Realized Risk | PVLA |
| Unified Institutional Score Composite Signal | 51.5 / 100 (HOLD) | 48.2 / 100 (HOLD) | Higher Composite | RAPP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RAPP vs PVLA Buy Guide
RAPP
BREAKDOWN
133d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
PVLA
CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RAPP nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.